Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology MHRF

Site:	Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology MHRF
Address:
City:	Moscow
State:	Moscow
Zip:	115522
Country:	Russia

Phase	Trial	Trial Status	Site Status	Drug	NCT#
2	Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)	Recruiting	Active	Belzutifan	NCT04924075